Ribosomal synthesis of backbone macrocyclic peptides

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Ribosomal synthesis of macrocyclic peptides has gained significant attention.
• Naturally occurring cyclic peptides possess enhanced stability and physiological activities, making them valuable drug leads.
• Enzymatic backbone cyclization confers peptidase resistance and thermodynamic stability.

Purpose of the Study:

• To review biosynthetic mechanisms of natural macrocyclic peptides.
• To explore emerging methodologies for synthetic cyclic peptide generation.
• To highlight the potential of cyclic peptides in drug discovery.

Main Methods:

• Focus on natural cyclic peptides: cyclotides, sunflower trypsin inhibitors (SFTIs), and cyanobactins.
• Discuss novel synthetic approaches: sortase-mediated ligation, protein splicing, and genetic code reprogramming.
• Review of existing literature on peptide cyclization.

Main Results:

• Detailed description of biosynthetic pathways for natural cyclic peptides.
• Overview of innovative techniques for artificial cyclic peptide synthesis.
• Emphasis on the structural and functional advantages of cyclic peptides.

Conclusions:

• Macrocyclic peptides are promising scaffolds for drug development.
• Advancements in synthetic methodologies expand the possibilities for cyclic peptide engineering.
• Understanding biosynthesis informs the design of novel therapeutic agents.